According to Adaptimmune Therapeutics's latest financial reports the company's current revenue (TTM ) is A$0.27 Billion. an increase over the revenue in the year 2023 that were of A$88.47 Million. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.